Recent VTRS News
- Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) • PR Newswire (US) • 03/23/2026 10:59:00 AM
- Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 • PR Newswire (US) • 03/19/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:04:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:03:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:16 AM
- Viatris tops forecasts as earnings and revenue beat expectations • IH Market News • 02/26/2026 02:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:52:59 PM
- Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 02/26/2026 11:59:00 AM
- Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend • PR Newswire (US) • 02/26/2026 11:55:00 AM
- FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia • PR Newswire (US) • 02/25/2026 11:59:00 AM
- Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026 • PR Newswire (US) • 02/03/2026 09:34:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 09:30:31 PM
- Viatris Appoints Matthew J. Maletta as Chief Legal Officer • PR Newswire (US) • 02/03/2026 01:30:00 PM
- Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure • PR Newswire (US) • 01/20/2026 11:59:00 AM
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer • PR Newswire (US) • 01/08/2026 02:05:00 PM
- Viatris Provides Pipeline Update on Four Regulatory Milestones • PR Newswire (US) • 12/18/2025 11:59:00 AM
- Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/17/2025 11:59:00 AM
- Viatris Recognized as 2025 Best Workplaces™ in Ontario and for Giving Back • PR Newswire (Canada) • 12/15/2025 02:00:00 PM
- Viatris reconnue comme l'un des meilleurs lieux de travail en Ontario et pour son engagement communautaire en 2025 • PR Newswire (Canada) • 12/15/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 12:00:47 PM
- Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited • PR Newswire (US) • 12/06/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 09:18:44 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
